Medicine
Metoprolol 25 mg tablet
Metoprolol 25 mg tablet is a generic prescription medicine for oral use, made by 27 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). Protect from light and moisture.
Key facts
- Active ingredient (INN)
- Metoprolol
- Brand
- Sold under the generic name
- Strength
- 25 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 30 tablets, 500 tablets and 201 more
- Manufacturers
- Alembic PharmaceuticalsIndiaAurobindo PharmaIndiaA-S Medication SolutionsAdvagen PharmaTruPharmaExelan PharmaceuticalsMylan PharmaceuticalsRising Pharma HoldingsMylan Institutional27 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). Protect from light and moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 16 January 2004
- Identifiers
- RxCUI 866514, 866924, 866511 +2DailyMed set ID 961248d5-d53c-408d-8f8f-d31885054f96, 59ed27b8-32b5-60c0-e063-6394a90a8a23, a2669da1-b712-5fd5-e053-2a95a90a52f3 +37NDC 51079-255, 67296-2323, 68071-5236 +37Application ANDA076704, ANDA202871, ANDA200981 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 27 labelers. The register lists 204 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 carton | 46708-290-10 | Alembic PharmaceuticalsIndia | 22 July 2013 |
| 30 tablet in 1 bottle | 46708-290-30 | Alembic PharmaceuticalsIndia | 22 July 2013 |
| 100 tablet in 1 bottle | 46708-290-31 | Alembic PharmaceuticalsIndia | 22 July 2013 |
| 500 tablet in 1 bottle | 46708-290-71 | Alembic PharmaceuticalsIndia | 22 July 2013 |
| 1000 tablet in 1 bottle | 46708-290-91 | Alembic PharmaceuticalsIndia | 22 July 2013 |
| 30 tablet in 1 bottle | 62332-112-30 | Alembic PharmaceuticalsIndia | 31 July 2016 |
| 100 tablet in 1 bottle | 62332-112-31 | Alembic PharmaceuticalsIndia | 31 July 2016 |
| 1000 tablet in 1 bottle | 62332-112-91 | Alembic PharmaceuticalsIndia | 31 July 2016 |
| 100 tablet, film coated in 1 bottle | 65862-062-01 | Aurobindo PharmaIndia | 11 September 2007 |
| 1000 tablet, film coated in 1 bottle | 65862-062-99 | Aurobindo PharmaIndia | 11 September 2007 |
| 1000 tablet, film coated in 1 bottle | 72888-004-00 | Advagen Pharma | 18 October 2024 |
| 100 tablet, film coated in 1 bottle | 72888-004-01 | Advagen Pharma | 18 October 2024 |
| 500 tablet, film coated in 1 bottle | 72888-004-05 | Advagen Pharma | 18 October 2024 |
| 1000 tablet in 1 bottle | 72888-208-00 | Advagen Pharma | 26 July 2024 |
| 100 tablet in 1 bottle | 72888-208-01 | Advagen Pharma | 26 July 2024 |
| 10000 tablet in 1 pouch | 72888-208-02 | Advagen Pharma | 26 July 2025 |
| 500 tablet in 1 bottle | 72888-208-05 | Advagen Pharma | 26 July 2024 |
| 1000 tablet in 1 bottle | 52817-250-00 | Trupharma | 30 August 2024 |
| 100 tablet in 1 bottle | 52817-250-10 | Trupharma | 30 August 2024 |
| 1000 tablet, film coated in 1 bottle | 52817-360-00 | TruPharma | 1 December 2018 |
| 100 tablet in 1 bottle | 76282-794-01 | Exelan Pharmaceuticals | 9 February 2026 |
| 1000 tablet in 1 bottle | 76282-794-10 | Exelan Pharmaceuticals | 9 February 2026 |
| 100 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 51079-255-20 | Mylan Institutional | 20 September 2004 |
| 100 tablet, film coated in 1 bottle, plastic | 0378-0018-01 | Mylan Pharmaceuticals | 23 February 2004 |
| 500 tablet, film coated in 1 bottle, plastic | 0378-0018-05 | Mylan Pharmaceuticals | 23 February 2004 |
| 100 tablet, film coated in 1 bottle | 57237-100-01 | Rising Pharma Holdings | 11 September 2007 |
| 1000 tablet, film coated in 1 bottle | 57237-100-99 | Rising Pharma Holdings | 11 September 2007 |
| 180 tablet, film coated in 1 bottle | 50090-2207-0 | A-S Medication Solutions | 30 October 2015 |
| 60 tablet, film coated in 1 bottle | 50090-2207-1 | A-S Medication Solutions | 30 October 2015 |
| 90 tablet, film coated in 1 bottle | 50090-2207-2 | A-S Medication Solutions | 30 October 2015 |
| 30 tablet, film coated in 1 bottle | 50090-2207-3 | A-S Medication Solutions | 30 October 2015 |
| 90 tablet, film coated in 1 bottle | 50090-5070-0 | A-S Medication Solutions | 1 June 2020 |
| 180 tablet, film coated in 1 bottle | 50090-7362-0 | A-S Medication Solutions | 18 October 2024 |
| 60 tablet, film coated in 1 bottle | 50090-7362-1 | A-S Medication Solutions | 18 October 2024 |
| 90 tablet, film coated in 1 bottle | 50090-7362-2 | A-S Medication Solutions | 18 October 2024 |
| 30 tablet, film coated in 1 bottle | 50090-7362-3 | A-S Medication Solutions | 18 October 2024 |
| 90 tablet, film coated in 1 bottle | 50090-7363-0 | A-S Medication Solutions | 18 October 2024 |
| 180 tablet in 1 bottle | 50090-7567-0 | A-S Medication Solutions | 30 May 2025 |
| 60 tablet in 1 bottle | 50090-7567-1 | A-S Medication Solutions | 30 May 2025 |
| 90 tablet in 1 bottle | 50090-7567-2 | A-S Medication Solutions | 30 May 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 7 August 1978 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Metoprolol
Clinical summary
Metoprolol is a beta-adrenergic blocker indicated for the treatment of hypertension, to lower blood pressure, among other approved uses. It is available as extended-release tablets, tablets and injection for oral and intravenous use. MedsAcross supplies Metoprolol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MetoprololFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Lopressor prescribing information (Validus Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Metoprolol 25 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.